Patient Understanding of Informed Consent in Interventional Pain Procedures
Evaluation of Patient Understanding of Informed Consent Before Interventional Pain Procedures: A Multicenter Randomized Controlled Study
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
Informed consent is an essential component of patient autonomy and ethical clinical care. However, patients may not fully understand the purpose, potential risks, and alternatives of an interventional procedure, even when routine verbal explanations and written consent forms are provided. Complex medical terminology, limited time, and differences in health literacy may affect patient comprehension. This prospective, multicenter, randomized, parallel-group study will investigate whether adding simplified and visually supported procedure-specific information cards to the standard informed consent process improves patient understanding before selected interventional pain procedures.
The study will include adult patients between 18 and 85 years of age who are scheduled to undergo one of the interventional pain procedures included in the approved protocol. Eligible procedures include piriformis injection, occipital nerve block, transforaminal epidural steroid injection, radiofrequency procedures, and intra-articular shoulder injection. Participants must be able to read, understand, and communicate in Turkish and must provide written informed consent for participation in the study.
Patients with serious cognitive impairment or mental incapacity affecting the consent process, severe hearing or visual loss, an active psychiatric episode affecting perception or expression, or a condition requiring urgent intervention will be excluded. Patients who do not agree to participate will also be excluded.
After eligibility assessment and written consent for study participation, all participants will receive the routine clinical explanation and the standard institution-approved informed consent form for the planned procedure. Participants will then be randomly assigned in a 1:1 ratio to the control group or the intervention group.
Participants in the control group will receive the standard informed consent process alone. Participants in the intervention group will receive the same standard informed consent process plus an ethics committee-approved simplified and visually supported information card specific to the planned procedure. The information card is an additional educational material and does not replace the physician's clinical explanation or the legally required informed consent form.
After completion of the information and consent process and before the planned clinical procedure, patient understanding will be assessed in both groups using a standardized teach-back assessment form. During the teach-back assessment, participants will be asked to explain the relevant information in their own words. The assessment will focus on understanding of the planned procedure and the key information provided during the consent process. The primary analysis will compare the teach-back understanding scores between the control and intervention groups.
The planned target enrollment is 360 participants across the participating centers. The study is planned to be conducted at the following centers: Sanliurfa Education and Research Hospital, Sanliurfa Mehmet Akif Inan Education and Research Hospital, and Ankara Bilkent City Hospital.
The study has received approval from the Harran University Clinical Research Ethics Committee under approval number HÜ-KAEK-2026-00079.
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究連絡先
研究連絡先
- 名前:Yağmur Can Dadakçı
- 電話番号:+905333599730
- メール:yagmurcand@gmail.com
研究場所
-
-
Ankara
-
Ankara、Ankara、トルコ(Türkiye)、06800
- Ankara Bilkent City Hospital
-
コンタクト:
- erkan yavuz akcaboy, prof. dr.
- 電話番号:+905054514664
- メール:akcaboyyavuz@gmail.com
-
-
Şanlıurfa
-
Sanliurfa、Şanlıurfa、トルコ(Türkiye)、63200
- Sanliurfa Education and Research Hospital
-
コンタクト:
- Yağmur Can Dadakçı
- 電話番号:+905333599730
- メール:yagmurcand@gmail.com
-
Sanliurfa、Şanlıurfa、トルコ(Türkiye)、63300
- Sanliurfa Mehmet Akif Inan Education and Research Hospital
-
コンタクト:
- ahmet cemal kaya
- 電話番号:+905393458515
- メール:ahmetcemal.kaya@saglik.gov.tr
-
-
参加基準
適格基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Adults aged 18 to 85 years.
- Patients scheduled to undergo an eligible interventional pain procedure included in the approved study protocol.
- Ability to read, understand, and communicate in Turkish.
- Ability to understand the study information and provide written informed consent for participation.
- Willingness to participate in the study.
Exclusion Criteria:
- Age below 18 years or above 85 years.
- Severe cognitive impairment, mental incapacity, or any condition that prevents reliable understanding of the consent information or completion of the teach-back assessment.
- Severe hearing or visual impairment that prevents the participant from receiving or understanding the study information, unless adequately corrected.
- Active psychiatric illness or acute psychiatric episode that may affect comprehension, communication, or voluntary consent.
- Emergency clinical condition requiring immediate intervention.
- Inability or unwillingness to complete the teach-back assessment.
- Inability or unwillingness to provide written informed consent for participation.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:他の
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
介入なし:Control Group
Participants in the control group will receive the standard verbal explanation and the institution-approved written informed consent form for the planned interventional pain procedure.
No additional educational material will be provided.
|
|
|
実験的:Intervention Group
Participants in the intervention group will receive the standard verbal explanation and the institution-approved written informed consent form for the planned interventional pain procedure, plus an ethics committee-approved simplified and visually supported procedure-specific information card.
|
An ethics committee-approved simplified and visually supported information card specific to the planned interventional pain procedure.
This card uses plain language and schematic illustrations to highlight key aspects such as procedure purpose, steps, and potential risks.
It is provided to participants in the intervention group as an educational supplement in addition to the standard informed consent process
|
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Patient Understanding of Informed Consent Assessed by Teach-Back
時間枠:Immediately after the informed consent process and before the planned clinical procedure
|
Patient understanding of the information provided during the informed consent process, assessed using a standardized teach-back form.
Participants will be asked to explain the key information about the planned interventional pain procedure in their own words.
The primary analysis will compare teach-back understanding between the control group and the intervention group.
|
Immediately after the informed consent process and before the planned clinical procedure
|
協力者と研究者
協力者
協力者
捜査官
捜査官
- 主任研究者:Yağmur Can Dadakçı、Sanliurfa Education and Research Hospital
研究記録日
主要日程の研究
研究開始 (推定)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
その他の研究ID番号
- HÜ-KAEK-2026-00079
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。